Could 4 months of chemo be enough for stomach cancer?

NCT ID NCT03399110

Ongoing Disease control Sponsor: Fudan University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares 4 months versus 6 months of chemotherapy (capecitabine and oxaliplatin) in 1024 stomach cancer patients who had surgery. The goal is to see if the shorter treatment works just as well to prevent cancer from coming back, while causing fewer side effects. Participants are adults aged 18-80 with stage II or III stomach cancer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastric adenocarcinoma gastric cancer gastric neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTRIC CANCER

Contacts and locations

Locations

[email protected]

Shenyang, China
Changhai Hospital

Shanghai, China
Jiangsu Cancer Hospital

Nanjing, China
Second Affiliated Hospital (Changzheng Hospital) of Naval Medical University

Shanghai, China
Shanghai East Hospital

Shanghai, China
Sun Yat-sen University Cancer Center

Guangzhou, China
The First Affiliated Hospital of Anhui Medical University

Hefei, China
The First Affiliated Hospital of University of Science and Technology of China

Hefei, China
The First Affiliated Hospital of Wannan Medical College

Wuhu, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.